However, a recent study using a selective FAK inhibitor VS-4718 significantly attenuated tumor progression, leading to the longer survival time of the PDAC mouse model by reducing tumor fibrosis and decreased numbers of tumor-infiltrating immunosuppressive cells [88]. This evidence concerns the gene PTK2 and neoplasm.